ELV Elevance Health
NYSE · SEC CIK 1156039 · EDGAR
- Bought, last 12 months
- $2.24M 3 purchases by 3 insiders
- Sold, last 12 months
- $1.74M 5 sales by 4 insiders
- Filings on record
- 154 since 2021-07-07, latest 2026-09-04 16:06
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| BOUDREAUX GAIL | Pres, CEO, Dir | $1.00M | — |
| Kendrick Charles Morgan JR | EVP, Pres, Commercial | — | $910.6K |
| COLLIS STEVEN H | Dir | $869.5K | — |
| Penczek Ronald W | CAO, Ctrl | — | $766.0K |
| PERU RAMIRO G | Dir | $366.1K | — |
| Dixon Robert L JR | Dir | — | $60.7K |
| SCHULMAN AMY W | Dir | — | $7,475 |
| Wessling Erin M | EVP, CLO | — | — |
| Craig Ryan R | EVP, Chief HR Off | — | — |
| Kaye Mark | EVP, CFO | — | — |
Transactions 207
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-03 | 2021-11-01 | ELV | Haytaian Peter D | EVP, Pres, DBG, IngenioRx | A - Grant | $0.00 | +1,167 | 22.7K | +5% | $0 |
| 2021-10-29 | 2021-10-28 | ELV | Penczek Ronald W | SVP, CAO | S - Sale | $436.00 | -1,150 | 2,009 | -36% | -$501.4K | |
| 2021-10-04 | 2021-10-01 | ELV | Alter Jeffrey D. | EVP, IngenioRx, Anthem Health | F - Tax | $375.93 | -311 | 5,107 | -6% | -$116.9K | |
| 2021-09-08 | 2021-09-04 | ELV | Patel Prakash R | EVP, Pres, DBG | F - Tax | $377.71 | -3,507 | 17.2K | -17% | -$1.32M | |
| 2021-09-03 | 2021-09-01 | ELV | DeVore Susan D. | Dir | A - Grant | $0.00 | +416 | 416 | New | $0 | |
| 2021-07-26 | 2021-07-23 | ELV | Schneider Ryan M. | Dir | P - Purchase | $384.36 | +1,300 | 4,714 | +38% | +$499.7K | |
| 2021-07-07 | 2021-07-02 | ELV | Norwood Felicia F | EVP, Pres, GBD | F - Tax | $387.20 | -5,543 | 25.0K | -18% | -$2.15M |
Purchase Sale Sale after option exercise All abbreviations